DUAL ACTIVATION OF ADENOSINE A(1) AND A(3) RECEPTORS MEDIATES PRECONDITIONING OF ISOLATED CARDIAC MYOCYTES

Citation
Jx. Wang et al., DUAL ACTIVATION OF ADENOSINE A(1) AND A(3) RECEPTORS MEDIATES PRECONDITIONING OF ISOLATED CARDIAC MYOCYTES, European journal of pharmacology, 320(2-3), 1997, pp. 241-248
Citations number
35
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
320
Issue
2-3
Year of publication
1997
Pages
241 - 248
Database
ISI
SICI code
0014-2999(1997)320:2-3<241:DAOAAA>2.0.ZU;2-8
Abstract
Ischemic preconditioning reduces post-ischemic myocardial injury by ac tivating myocellular adenosine A(1) receptors. Adenosine A(3) receptor s have also been implicated but there is no evidence for A(3) receptor s in cardiac myocytes. The aim of this study was to develop a model of preconditioning in isolated cardiac myocytes to evaluate the role of the adenosine A(1) and A(3) receptors in preconditioning-induced prote ction from ischemic injury. Reverse transcription polymerase chain rea ction (PCR) was also employed to establish the presence of adenosine A (3) receptors in these cells. In the preconditioning studies, ischemic injury was simulated by exposing isolated rabbit myocytes (placed in the cell chamber and paced at 1 Hz) to buffer containing (in mM) 2'-de oxyglucose (20), NaCN (1), Na+-lactate (20), KCl (10) at pH 6.6 (37 de grees C). Changes of diastolic and systolic cell length were monitored with an optical-video edge imaging system, and hypercontracture was a ssessed as an index of irreversible cell injury. Preconditioning (2 mi n brief ischemia and 15 min reperfusion) significantly reduced cell in jury resulting from a subsequent prolonged ischemia (10 min) and reper fusion (15 min), as indicated by a reduction in the incidence of cell hypercontracture from 67+/-6% to 29+/-5% (P <0.001). Preconditioning-i nduced cardioprotection was only partially blocked by a maximally effe ctive concentration (100 nM) of the adenosine A(1) receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) (cell hypercontracture=43/-3%, P <0.05 vs. control) but completely blocked by either the combin ation of DPCPX (100 nM) with the adenosine A(1)/A(3) receptor antagoni st CPXS+8-(4-carboxyethylphenyl)-1,3-dipropylxanthine (BWA1433; 1 mu M ) or the non-selective adenosine receptor antagonist, 8-(p-sulfophenyl )theophylline (8-SPT; 100 mu M) (cell hypercontracture=64+/-4%, 59+/-5 %, respectively; P=NS vs. control). In non-hypercontractured myocytes, preconditioning also substantially enhanced the recovery of the contr actile amplitude and, similarly, this effect was only partially blocke d by DPCPX but completely blocked by either the combination of DPCPX w ith BWA1433, or 8-SPT. These studies suggest that preconditioning prot ects isolated cardiac myocytes from ischemic injury independent of oth er cell types. and that maximal preconditioning-induced cardioprotecti on requires activation of both adenosine A(1) and A(3) receptors. Reve rse transcription-PCR using primers for the rabbit receptor provide ev idence for the presence of adenosine A(3) receptors in these cells.